1. Home
  2. PAR vs HRMY Comparison

PAR vs HRMY Comparison

Compare PAR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAR
  • HRMY
  • Stock Information
  • Founded
  • PAR 1968
  • HRMY 2017
  • Country
  • PAR United States
  • HRMY United States
  • Employees
  • PAR N/A
  • HRMY N/A
  • Industry
  • PAR Office Equipment/Supplies/Services
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAR Miscellaneous
  • HRMY Health Care
  • Exchange
  • PAR Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • PAR 2.7B
  • HRMY 1.8B
  • IPO Year
  • PAR N/A
  • HRMY 2020
  • Fundamental
  • Price
  • PAR $69.06
  • HRMY $34.00
  • Analyst Decision
  • PAR Strong Buy
  • HRMY Strong Buy
  • Analyst Count
  • PAR 7
  • HRMY 9
  • Target Price
  • PAR $79.86
  • HRMY $54.44
  • AVG Volume (30 Days)
  • PAR 436.2K
  • HRMY 653.9K
  • Earning Date
  • PAR 08-07-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • PAR N/A
  • HRMY N/A
  • EPS Growth
  • PAR N/A
  • HRMY 13.13
  • EPS
  • PAR N/A
  • HRMY 2.62
  • Revenue
  • PAR $383,768,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • PAR $30.06
  • HRMY $20.33
  • Revenue Next Year
  • PAR $16.97
  • HRMY $17.67
  • P/E Ratio
  • PAR N/A
  • HRMY $12.97
  • Revenue Growth
  • PAR 37.95
  • HRMY 20.62
  • 52 Week Low
  • PAR $43.50
  • HRMY $26.47
  • 52 Week High
  • PAR $82.24
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • PAR 58.95
  • HRMY 58.91
  • Support Level
  • PAR $65.57
  • HRMY $31.70
  • Resistance Level
  • PAR $70.89
  • HRMY $35.08
  • Average True Range (ATR)
  • PAR 1.98
  • HRMY 0.95
  • MACD
  • PAR 0.23
  • HRMY 0.27
  • Stochastic Oscillator
  • PAR 79.49
  • HRMY 71.80

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: